TGF-β-activated kinase 1 (TAK1) is an in vivo druggable target for reverting pancreatic cancer chemoresistance

被引：2
|
作者：
Melisi, D. [1 ]
Xia, Q. [1 ]
Abbruzzese, J. L. [1 ]
Chiao, P. J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70295-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [11] TGF-β1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1
    Dvashi, Zeev
    Goldberg, Mordechai
    Adir, Orit
    Shapira, Michal
    Pollack, Ayala
    PLOS ONE, 2015, 10 (04):
  • [12] TGF-β Activated Kinase 1 (TAK1) Inhibition Suppresses Synovial Inflammation and Tissue Destruction Mediated by Activated Juvenile Idiopathic Arthritis Synovial Fibroblasts
    Shanta, Meena Afroze
    Panipinto, Paul
    Singh, Anil
    Nigrovic, Peter
    Henderson, Lauren
    Ahmed, Salahuddin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5264 - 5265
  • [13] TGF-β-Activated Kinase 1 (TAK1) Signaling Regulates TGF-β-Induced WNT-5A Expression in Airway Smooth Muscle Cells via Sp1 and β-Catenin
    Kumawat, Kuldeep
    Menzen, Mark H.
    Slegtenhorst, Ralph M.
    Halayko, Andrew J.
    Schmidt, Martina
    Gosens, Reinoud
    PLOS ONE, 2014, 9 (04):
  • [14] TAK1 is a druggable kinase for diffuse large B-cell lymphoma
    Wu, Yuanyuan
    Yang, Riyun
    Ming, Yue
    Xu, Yuanpei
    Chen, Hao
    Yao, Min
    Chen, Xia
    Mao, Renfang
    Fan, Yihui
    CELL BIOCHEMISTRY AND FUNCTION, 2019, 37 (03) : 153 - 160
  • [15] TAK1 is a druggable kinase for diffuse large B-cell lymphoma
    Wu, Y.
    Fan, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 39 - 40
  • [16] Small molecule inhibition of TGFβ-activated kinase (TAK1) results in reduced heterotopic ossification
    Strong, Amy
    Spreadborough, Philip
    Pagani, Chase
    Haskins, Ryan
    Dey, Devaveena
    Grimm, Patrick
    Kaneko, Keiko
    Marini, Simone
    Huber, Amanda
    Hwang, Charles
    Westover, Kenneth
    Mishina, Yuji
    Bradley, Matthew
    Levi, Benjamin
    Davis, Thomas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 266 - 266
  • [17] Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1 (vol 103, pg 1190, 2011)
    Melisi, Davide
    Xia, Qianghua
    Paradiso, Genni
    Ling, Jianhua
    Moccia, Tania
    Carbone, Carmine
    Budillon, Alfredo
    Abbruzzese, James L.
    Chia, Paul J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 117 (02): : 381 - 381
  • [18] TGFβ1 ACTIVATED KINASE-1 (TAK1) MODULATES RENAL FIBROSIS AND TUBULAR APOPTOSIS IN THE OBSTRUCTED KIDNEY
    Ma, F.
    Tesch, G.
    Ozols, E.
    Xie, M.
    Schneider, M.
    Nikolic-Paterson, D.
    NEPHROLOGY, 2010, 15 : 47 - 48
  • [19] TGFβ-activated kinase 1 (TAK1)-binding proteins (TAB) 2 and 3 negatively regulate autophagy
    Takaesu, Giichi
    Kobayashi, Takashi
    Yoshimura, Akihiko
    JOURNAL OF BIOCHEMISTRY, 2012, 151 (02): : 157 - 166
  • [20] CARTILAGE INJURY SUPPRESSES ENDOGENOUS RETINOIC ACID THROUGH ACTIVATION OF TGFβ-ACTIVATED KINASE 1 (TAK1)
    Zhu, L.
    Ismail, H.
    Chanalaris, A.
    Muhammad, H.
    Lympany, S.
    Vincent, T. L.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S107 - S107
12345